Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Enters Alliance with Luxembourg Biobank

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has inked an agreement with the Integrated Biobank of Luxembourg under which it will use Life Technologies' Applied Biosystems SOLiD System to sequence its biospecimen samples.

The IBBL is an independent, non-profit biobanking and biotech foundation that has focused initially on collecting, storing, analyzing, and distributing cancer biospecimen samples. It was co-founded in 2008 by Luxembourg's three public research centers — CRP-Santé, CRP-Henri Tudor, CRP-Gabriel Lippmann — the University of Luxembourg, and Arizona's Translational Genomics Research Institute.

Life Technologies said that the collaboration could result in a greater understanding of the genetic basis for many diseases and could eventually have application in using sequencing for clinical diagnostics.

"By partnering with Life Technologies, IBBL is gaining access to cutting-edge sequencing technology, an important step to building an advanced technology infrastructure and a successful biomedical research industry in Luxembourg," Jean-Claude Schmit, president of IBBL, said in a statement.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.